Author Index

A

  • Abd El-Gaid, Salwa Value of F-18 FDG PET/CT Compared to Conventional Imaging in changing management of Patients with Differentiated Thyroid Cancer before radioactive iodine ablation. [Volume 25, Issue 2, 2022, Pages 63-77]
  • Abdelmoteleb, Asmaa Magdy ASSESSMENT OF TREATMENT RESPONSE TO 131I THERAPY FOR PATIENTS WITH DIFFERENTIATED THYROID CARCINOMA IN THE PAST THREE YEARS (Single Institutional Experience) [Volume 25, Issue 2, 2022, Pages 45-62]
  • Abougabal, Mahasen Amin The correlation between 18F FDG PET CT metabolic parameters and pathological prognostic factors in early breast cancer patients [Volume 25, Issue 2, 2022, Pages 30-44]
  • Ahmad, Yasser Mohamed ASSESSMENT OF TREATMENT RESPONSE TO 131I THERAPY FOR PATIENTS WITH DIFFERENTIATED THYROID CARCINOMA IN THE PAST THREE YEARS (Single Institutional Experience) [Volume 25, Issue 2, 2022, Pages 45-62]

B

  • Badawy, Ahmed Mohamed Role of FDG/CT Scan Quantitative Analysis in Assessment of both Hodgkin and Non-Hodgkin lymphoma [Volume 25, Issue 2, 2022, Pages 15-29]
  • Badawy, Ahmed Mohamed ASSESSMENT OF TREATMENT RESPONSE TO 131I THERAPY FOR PATIENTS WITH DIFFERENTIATED THYROID CARCINOMA IN THE PAST THREE YEARS (Single Institutional Experience) [Volume 25, Issue 2, 2022, Pages 45-62]

E

  • Elantably, Ismail Mohamed Value of F-18 FDG PET/CT Compared to Conventional Imaging in changing management of Patients with Differentiated Thyroid Cancer before radioactive iodine ablation. [Volume 25, Issue 2, 2022, Pages 63-77]
  • El-rasad, Shimaa Role of FDG/CT Scan Quantitative Analysis in Assessment of both Hodgkin and Non-Hodgkin lymphoma [Volume 25, Issue 2, 2022, Pages 15-29]
  • Elsaban, Khalid Reda Role of FDG/CT Scan Quantitative Analysis in Assessment of both Hodgkin and Non-Hodgkin lymphoma [Volume 25, Issue 2, 2022, Pages 15-29]
  • Elsayed, Nahla Dessoki Role of FDG/CT Scan Quantitative Analysis in Assessment of both Hodgkin and Non-Hodgkin lymphoma [Volume 25, Issue 2, 2022, Pages 15-29]

H

  • Hassan, Marwa Abd Allah Role of FDG/CT Scan Quantitative Analysis in Assessment of both Hodgkin and Non-Hodgkin lymphoma [Volume 25, Issue 2, 2022, Pages 15-29]
  • Husseini, Maha Abd Elkareem Does blood glucose level have influence on 18F-FDG metabolic indices in normal and neoplastic tissues [Volume 25, Issue 2, 2022, Pages 8-14]
  • Husseini, Maha Abd Elkareem The correlation between 18F FDG PET CT metabolic parameters and pathological prognostic factors in early breast cancer patients [Volume 25, Issue 2, 2022, Pages 30-44]

I

  • Ibrahim, Dalia Value of F-18 FDG PET/CT Compared to Conventional Imaging in changing management of Patients with Differentiated Thyroid Cancer before radioactive iodine ablation. [Volume 25, Issue 2, 2022, Pages 63-77]
  • Ibrahim, Hassan Salah Estimation of The Patient’s Specific Effective Dose for The Total Body F18- FDG PET/CT Scan, A Single Centre Experience [Volume 25, Issue 2, 2022, Pages 78-88]

K

  • Kandil, Ahmed ASSESSMENT OF TREATMENT RESPONSE TO 131I THERAPY FOR PATIENTS WITH DIFFERENTIATED THYROID CARCINOMA IN THE PAST THREE YEARS (Single Institutional Experience) [Volume 25, Issue 2, 2022, Pages 45-62]

M

  • Maamoun, Marwa Mohammad Does blood glucose level have influence on 18F-FDG metabolic indices in normal and neoplastic tissues [Volume 25, Issue 2, 2022, Pages 8-14]
  • Mohamed, Ahmed Abdel Hafeez The correlation between 18F FDG PET CT metabolic parameters and pathological prognostic factors in early breast cancer patients [Volume 25, Issue 2, 2022, Pages 30-44]

N

  • Nasr, Nourhan Kotb The correlation between 18F FDG PET CT metabolic parameters and pathological prognostic factors in early breast cancer patients [Volume 25, Issue 2, 2022, Pages 30-44]

S

  • Saad Ahmed, Ibrahim Elsayed Availability and Affordability Of PET Tracers, The Challenges and Opportunities in Developing Countries [Volume 25, Issue 2, 2022, Pages 1-7]
  • Saad Ahmed, Ibrahim Elsayed Estimation of The Patient’s Specific Effective Dose for The Total Body F18- FDG PET/CT Scan, A Single Centre Experience [Volume 25, Issue 2, 2022, Pages 78-88]

T

  • Tawakol, Ahmed ASSESSMENT OF TREATMENT RESPONSE TO 131I THERAPY FOR PATIENTS WITH DIFFERENTIATED THYROID CARCINOMA IN THE PAST THREE YEARS (Single Institutional Experience) [Volume 25, Issue 2, 2022, Pages 45-62]